Jan W Gratama1, Jaco Kraan, Mike Keeney, Viv Granger, David Barnett. 1. Laboratory for Clinical and Tumor Immunology, Department of Internal Oncology, Erasmus Medical Center-Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. gratama@immh.azr.nl
Abstract
BACKGROUND: Enumeration of CD4(+) and CD8(+) T-cell subsets provides relevant information for diagnosis and monitoring of patients with cellular immunodeficiencies. As a result, an external quality assurance scheme was implemented in Belgium, The Netherlands, and Luxembourg in 1995. A workshop was held to train the participants in state-of-the art technology for assessment of absolute T-cell subset counts (i.e., a three or four-color, single-platform assay with lymphocyte gating based on CD45 and sideward light scatter) with the aim to achieve between-site coefficients of variation (CVs) <10% and within-site CVs <5% for > or =75% of the participants. METHODS: Three send-outs of stabilized blood from a healthy donor were distributed to 55 laboratories, each with the request to perform the standard assay on three occasions. For comparison, each laboratory performed its local technique in parallel. RESULTS: With the standard technique, between-site CVs of approximately 8% (CD3+ T cells), approximately 9% (CD4+ T cells), and approximately 10% (CD8+ T cells) were achieved. Within-site CVs were <5% for 82% (CD3+ T cells) and approximately 70% (CD4+ and CD8+ subsets) of the participants. Local techniques yielded between-site CVs of 13%-17% for CD3+, CD4+, and CD8+ T cells. CONCLUSIONS: The state-of-the-art technology for T-cell subset enumeration was implemented successfully among 55 Belgian-Dutch laboratories and resulted in significant reductions of between-site variation of absolute CD3+, CD4+, and CD8+ T-cell counts. Copyright 2002 Wiley-Liss, Inc.
BACKGROUND: Enumeration of CD4(+) and CD8(+) T-cell subsets provides relevant information for diagnosis and monitoring of patients with cellular immunodeficiencies. As a result, an external quality assurance scheme was implemented in Belgium, The Netherlands, and Luxembourg in 1995. A workshop was held to train the participants in state-of-the art technology for assessment of absolute T-cell subset counts (i.e., a three or four-color, single-platform assay with lymphocyte gating based on CD45 and sideward light scatter) with the aim to achieve between-site coefficients of variation (CVs) <10% and within-site CVs <5% for > or =75% of the participants. METHODS: Three send-outs of stabilized blood from a healthy donor were distributed to 55 laboratories, each with the request to perform the standard assay on three occasions. For comparison, each laboratory performed its local technique in parallel. RESULTS: With the standard technique, between-site CVs of approximately 8% (CD3+ T cells), approximately 9% (CD4+ T cells), and approximately 10% (CD8+ T cells) were achieved. Within-site CVs were <5% for 82% (CD3+ T cells) and approximately 70% (CD4+ and CD8+ subsets) of the participants. Local techniques yielded between-site CVs of 13%-17% for CD3+, CD4+, and CD8+ T cells. CONCLUSIONS: The state-of-the-art technology for T-cell subset enumeration was implemented successfully among 55 Belgian-Dutch laboratories and resulted in significant reductions of between-site variation of absolute CD3+, CD4+, and CD8+ T-cell counts. Copyright 2002 Wiley-Liss, Inc.
Authors: U Koehl; K Bochennek; R Esser; A Brinkmann; R Quaritsch; M Becker; J Soerensen; P Bader; D Schwabe; T Klingebiel; J Fischer; S Y Zimmermann Journal: Int J Hematol Date: 2007-12-18 Impact factor: 2.490
Authors: Lance E Hultin; Marianne Chow; Beth D Jamieson; Maurice R G O'Gorman; Frederick A Menendez; Luann Borowski; Thomas N Denny; Joseph B Margolick Journal: Cytometry B Clin Cytom Date: 2010-05 Impact factor: 3.058
Authors: Madhuri R Thakar; Philip R Abraham; Sunil Arora; Pachamuthu Balakrishnan; Bhaswati Bandyopadhyay; Ameeta A Joshi; K Rekha Devi; Ravi Vasanthapuram; Madhu Vajpayee; Anita Desai; Janardhanan Mohanakrishnan; Kanwar Narain; Krishnangshu Ray; Shilpa S Patil; Ravinder Singh; Anuj Singla; Ramesh S Paranjape Journal: AIDS Res Ther Date: 2011-10-03 Impact factor: 2.250